2020 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y(12) Receptor Antagonists in the Asia-Pacific Region

The unique characteristics of patients with acute coronary syndrome in the Asia-Pacific region mean that international guidelines on the use of dual antiplatelet therapy (DAPT) cannot be routinely applied to these populations. Newer generation P2Y(12) inhibitors (i.e. ticagrelor and prasugrel) have...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur Cardiol
Päätekijät: Tan, Jack WC, Chew, Derek P, Abdul Kader, Muhamad Ali SK, Ako, Junya, Bahl, Vinay K, Chan, Mark, Park, Kyung Woo, Chandra, Praveen, Hsieh, I-Chang, Huan, Do Quang, Johar, Sofian, Juzar, Dafsah Arifa, Kim, Byeong-Keuk, Lee, Cheol Whan, Lee, Michael Kang-Yin, Li, Yi-Heng, Almahmeed, Wael, Sison, Eric Oliver, Tan, Doreen, Wang, Yu-Chen, Yeh, Shiuan Jong, Montalescot, Gilles
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Radcliffe Cardiology 2021
Aiheet:
APSC Consensus Statements
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7941380/
https://ncbi.nlm.nih.gov/pubmed/33708263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ecr.2020.40
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia